Exchange: NASDAQ·Updated 07:49 PM EDT
URGN logo

URGN UroGen Pharma Ltd

$43.09
$0.53
(1.22%)
Today
Closed $43.09
$0.00
(0.00%)
After Hours
Reported EarningsAug 5
Mkt Cap$2.13B
Vol749,045.00

About URGN

UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
35

Bearish Sentiment

How do you feel about URGN?

Advertisement|Remove ads.